Atezolizumab with chemotherapy for advanced or recurrent endometrial cancer: does targeting PD-1 or PD-L1 matter in this clinical situation?
@article{GPM10164, author = {Chelsea E. Stewart and Dana M. Chase}, title = {Atezolizumab with chemotherapy for advanced or recurrent endometrial cancer: does targeting PD-1 or PD-L1 matter in this clinical situation?}, journal = {Gynecology and Pelvic Medicine}, volume = {0}, number = {0}, year = {2024}, keywords = {}, abstract = {}, issn = {2617-4499}, url = {https://gpm.amegroups.org/article/view/10164} }